BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8647239)

  • 1. Specific transformation abolishes cyclin D1 fluctuation throughout the cell cycle.
    Pusch O; Soucek T; Wawra E; Hengstschläger-Ottnad E; Bernaschek G; Hengstschläger M
    FEBS Lett; 1996 May; 385(3):143-8. PubMed ID: 8647239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle-dependent expression of cyclin D1 and a 45 kD protein in human A549 lung carcinoma cells.
    Wu F; Bui KC; Buckley S; Warburton D
    Am J Respir Cell Mol Biol; 1994 Apr; 10(4):437-47. PubMed ID: 8136159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 expression is regulated by the retinoblastoma protein.
    Müller H; Lukas J; Schneider A; Warthoe P; Bartek J; Eilers M; Strauss M
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):2945-9. PubMed ID: 8159685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immortalization of human fibroblasts by SV40 large T antigen results in the reduction of cyclin D1 expression and subunit association with proliferating cell nuclear antigen and Waf1.
    Peterson SR; Gadbois DM; Bradbury EM; Kraemer PM
    Cancer Res; 1995 Oct; 55(20):4651-7. PubMed ID: 7553644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rescue of defective mitogenic signaling by D-type cyclins.
    Roussel MF; Theodoras AM; Pagano M; Sherr CJ
    Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6837-41. PubMed ID: 7624328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.
    Jiang W; Kahn SM; Zhou P; Zhang YJ; Cacace AM; Infante AS; Doi S; Santella RM; Weinstein IB
    Oncogene; 1993 Dec; 8(12):3447-57. PubMed ID: 8247550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1.
    Lukas J; Müller H; Bartkova J; Spitkovsky D; Kjerulff AA; Jansen-Dürr P; Strauss M; Bartek J
    J Cell Biol; 1994 May; 125(3):625-38. PubMed ID: 8175885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin E-induced S phase without activation of the pRb/E2F pathway.
    Lukas J; Herzinger T; Hansen K; Moroni MC; Resnitzky D; Helin K; Reed SI; Bartek J
    Genes Dev; 1997 Jun; 11(11):1479-92. PubMed ID: 9192874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling by ABL oncogenes through cyclin D1.
    Afar DE; McLaughlin J; Sherr CJ; Witte ON; Roussel MF
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9540-4. PubMed ID: 7568169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression.
    Hiyama H; Iavarone A; LaBaer J; Reeves SA
    Oncogene; 1997 May; 14(21):2533-42. PubMed ID: 9191053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the cyclin-dependent kinase inhibitor p16 during the ongoing cell cycle.
    Soucek T; Pusch O; Hengstschläger-Ottnad E; Wawra E; Bernaschek G; Hengstschläger M
    FEBS Lett; 1995 Oct; 373(2):164-9. PubMed ID: 7589458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different roles for cyclins D1 and E in regulation of the G1-to-S transition.
    Resnitzky D; Reed SI
    Mol Cell Biol; 1995 Jul; 15(7):3463-9. PubMed ID: 7791752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line.
    Hochhauser D; Schnieders B; Ercikan-Abali E; Gorlick R; Muise-Helmericks R; Li WW; Fan J; Banerjee D; Bertino JR
    J Natl Cancer Inst; 1996 Sep; 88(18):1269-75. PubMed ID: 8797766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells.
    Liu JJ; Chao JR; Jiang MC; Ng SY; Yen JJ; Yang-Yen HF
    Mol Cell Biol; 1995 Jul; 15(7):3654-63. PubMed ID: 7791772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein.
    Zhu X; Ohtsubo M; Böhmer RM; Roberts JM; Assoian RK
    J Cell Biol; 1996 Apr; 133(2):391-403. PubMed ID: 8609171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic collaboration of the cyclin D1 (PRAD1, bcl-1) gene with a mutated p53 and an activated ras oncogene in neoplastic transformation.
    Uchimaru K; Endo K; Fujinuma H; Zukerberg L; Arnold A; Motokura T
    Jpn J Cancer Res; 1996 May; 87(5):459-65. PubMed ID: 8641982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of p53 in coordinated regulation of cyclin D1 and p21 gene expression by the adenovirus E1A and E1B oncogenes.
    Spitkovsky D; Steiner P; Gopalkrishnan RV; Eilers M; Jansen-Dürr P
    Oncogene; 1995 Jun; 10(12):2421-5. PubMed ID: 7784093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts.
    Pagano M; Theodoras AM; Tam SW; Draetta GF
    Genes Dev; 1994 Jul; 8(14):1627-39. PubMed ID: 7958844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells.
    Arber N; Doki Y; Han EK; Sgambato A; Zhou P; Kim NH; Delohery T; Klein MG; Holt PR; Weinstein IB
    Cancer Res; 1997 Apr; 57(8):1569-74. PubMed ID: 9108461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.